The Impact of New Emerging Drugs in the Treatment of Multiple Myeloma:Is there Still a Role for PBSC Transplantation?

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 1, 2007-01 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Towards a new age in the treatment of multiple myeloma

By Piazza Francesco   Gurrieri Carmela   Trentin Livio   Semenzato Gianpietro  

Annals of Hematology, Vol. 86, Iss. 3, 2007-03 ,pp. : 159-172

Springer Publishing Company

Access to resources Recommend Favorite

Novel Targeted Therapies and Combinations for the Treatment of Multiple Myeloma

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 2-15

Bentham Science Publishers

Access to resources Recommend Favorite

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

By Witzens Mathias  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 467-470

Springer Publishing Company

Access to resources Recommend Favorite

Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma - a randomized multicenter study. The European study group of erythropoietin (Epoetin Beta) treatment in multiple myeloma and non-Hodgkin's lymphoma

By Fossa A.   Brandhorst D.   Myklebust J.H.   Seeber S.   Nowrousian M.R.  

Experimental Hematology, Vol. 27, Iss. 11, 1999-11 ,pp. : 1621-1626

Elsevier

Access to resources Recommend Favorite